Anne Osdoit - Profile and Investment Details

Investor Profile

Anne Osdoit is a Venture Capital, Investor based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Noema Pharma, ENYO Pharma, Gradient Denervation Technologies, Abivax, FeetMe, Aledia, Genespire, MedDay, CorVent Medical, HighLife, Redx Pharma, Breath Therapeutics, BrightHeart, EnginZyme, Asceneuron, Crescendo Biologics, Enthera, AblaCare, DNA Script, Comet Biorefining, Green Biologics, Hookipa Pharma, Inventiva PharmaCinCor Pharma, GenSight Biologics, SafeHeal, Micropep Technologies, InCarda Therapeutics, AFYX Therapeutics, Sitryx Therapeutics, Pyrowave, Nitrome Biosciences, Delinia, EnobraQ, Pi-Cardia, Twenga, NodThera, HotSpot Therapeutics, Microphyt, Catamaran Bio, Inotrem, Mainstay Medical, Biotalys, Corwave, Rgenix, Synthace, Zyl, Biosyntia, Checkmate Pharmaceuticals, AFYREN, MISSION Therapeutics, Myricx Pharma, CelluComp, Corvidia, Cardiologs, ReCor Medical, myTomorrows, Protera, Comet Therapeutics, MD Start, DMC Biotechnologies, Mauna Kea Technologies, Castle Biosciences, Avantium Technologies, Twentyeight-Seven Therapeutics, Moon Surgical, RefleXion Medical, TISSIUM, Odoo, Shockwave Medical, PinCell s.r.l., Epsilen Bio, LimFlow SA, Erydel, IOmx Therapeutics, ObsEva, Pixium Vision, POLYNEURON, . Over time, Anne Osdoit has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Anne Osdoit is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Genetics, Equipment Manufacturing, Computer Vision, Wellness, Healthcare Innovation, Life Science, Robotics, Information Technology (IT), Ergonomics, 3D Technology, Software, Manufacturing, Biotechnology, Medical Devices, Genomics, Communities, Health Diagnostics, Medical, Information Technology, B2B, Therapeutics, Machine Learning, Emergency Medicine, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Anne Osdoit, as their portfolio suggests a familiarity and interest in this area.

Understanding Anne Osdoit’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.